USP18 expression data from multiple cancer types and clinical annotations from human AML, ACC, and LGG patients were analyzed using GEPIA257. The top and bottom quartiles were used to define groups for analysis. For breast and lung cancer patients, the relapse-free and overall survival correlation was assessed by KMplot58, respectively. Patient cohorts were restricted to SEER prevalence. For lung cancer patients, GSE30219 was used.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.